Company Filing History:
Years Active: 2012
Title: Michael Dechao Yu: Innovator in Biotechnological Advancements
Introduction
Michael Dechao Yu is a prominent inventor based in Chengdu, China. He has made significant contributions to the field of biotechnology, particularly in the area of vascular biology. His innovative work focuses on developing solutions for neovascularization-related diseases.
Latest Patents
Michael Dechao Yu holds a patent for the invention titled "Inhibition of neovascularization with a soluble chimeric protein comprising VEGF FLT-1 and KDR domains." This patent describes novel soluble chimeric fusion proteins that include amino acid sequences derived from the vascular endothelial growth factor (VEGF) receptors flt-1 and KDR, specifically domain 4 of KDR. The claimed chimeric fusion proteins are designed to antagonize the endothelial cell proliferative and angiogenic activity of VEGF, making them useful in treating diseases related to neovascularization. He has 1 patent to his name.
Career Highlights
Michael Dechao Yu is associated with Chengdu Kanghong Biotechnologies Co., Ltd., where he applies his expertise in biotechnology to advance research and development. His work has the potential to impact various therapeutic areas, particularly those involving vascular health.
Collaborations
(Section skipped due to space constraints.)
Conclusion
Michael Dechao Yu's innovative contributions to biotechnology, particularly through his patent on chimeric fusion proteins, highlight his role as a key inventor in the field. His work continues to pave the way for advancements in the treatment of neovascularization-related diseases.